Lung Involvements in Rheumatic Diseases: Update on the Epidemiology, Pathogenesis, Clinical Features, and Treatment

Figure 3

A schematic picture on screening and monitoring rheumatic disease associated lung involvements. DLCO: diffusing capacity of carbon monoxide; FVC: forced vital capacity; HRTC: high resolution computed tomography; ILD: interstitial lung disease; NT-proBNP: N-terminal probrain natriuretic peptide; PAH: pulmonary arterial hypertension; TR: tricuspid regurgitation.